Join Growin Stock Community!

Caris life sciences, inc.CAI.US Overview

US StockHealthcare
(No presentation for CAI)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

CAI AI Insights

CAI Overall Performance

CAI AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

CAI Recent Performance

-0.94%

Caris life sciences, inc.

0.05%

Avg of Sector

-0.31%

S&P500

CAI PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

CAI Key Information

CAI Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

CAI Profile

CAI International, Inc. operates as transportation finance and logistics company in the United States, Switzerland, France, Korea, Singapore, rest of Asia, rest of Europe, and internationally. The company operates through two segments, Container Leasing and Logistics. It leases, re-leases, and disposes equipment; and contracts for the repair, repositioning, and storage of equipment. The company leases its container equipment to lessees under long-term, short-term, and finance leases. It also sells containers; and manages equipment for to third-party investors, as well as sells used containers. In addition, the company offers domestic and international logistics services, including intermodal, truck brokerage, port drayage, warehousing, international ocean freight, and freight forwarding, as well as the arrangement and coordination of international air freight services and customs brokerage; international export and import services for full container loads, less than container loads, perishable cargo, project cargo, and airfreight; and transportation management services and technology solutions, including shipment optimization, load consolidation, mode selection, carrier management, load planning and execution, and Web-based shipment visibility. As of December 31, 2019, it had a container fleet comprised 1,727,816 cost equivalent units. The company was formerly known as Container Applications International, Inc. and changed its name to CAI International, Inc. in February 2007. CAI International, Inc. was founded in 1989 and is headquartered in San Francisco, California.

Price of CAI

CAI FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

CAI Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.91
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
7.00
PB Ratio
11.34
Price-to-FCF
171.26
METRIC
VALUE
vs. INDUSTRY
Gross Margin
66.40%
Net Margin
-66.25%
Revenue Growth (YoY)
113.23%
Profit Growth (YoY)
288.52%
3-Year Revenue Growth
42.68%
3-Year Profit Growth
49.93%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-1.91
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
7.00
PB Ratio
11.34
Price-to-FCF
171.26
Gross Margin
66.40%
Net Margin
-66.25%
Revenue Growth (YoY)
113.23%
Profit Growth (YoY)
288.52%
3-Year Revenue Growth
42.68%
3-Year Profit Growth
49.93%

  • When is CAI's latest earnings report released?

    The most recent financial report for Caris life sciences, inc. (CAI) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CAI's short-term business performance and financial health. For the latest updates on CAI's earnings releases, visit this page regularly.

  • How much debt does CAI have?

    As of the end of the reporting period, Caris life sciences, inc. (CAI) had total debt of 169K, with a debt ratio of 0. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does CAI have?

    At the end of the period, Caris life sciences, inc. (CAI) held Total Cash and Cash Equivalents of 797.8M, accounting for 0.71 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does CAI go with three margins increasing?

    In the latest report, Caris life sciences, inc. (CAI) did not achieve the “three margins increasing” benchmark, with a gross margin of 75.43%%, operating margin of 17.9%%, and net margin of -132.44%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CAI's profit trajectory and future growth potential.

  • What are the PEG ratio and PE ratio of CAI?

    The latest valuation data shows Caris life sciences, inc. (CAI) has a Price-To-Earnings (PE) ratio of -29.07 and a Price/Earnings-To-Growth (PEG) ratio of -0.12. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.